Long Non-coding RNAs in Tuberculosis: From Immunity to Biomarkers

被引:10
|
作者
Zhang, Xianyi [1 ,2 ]
Chen, Chan [2 ]
Xu, Yuzhong [2 ]
机构
[1] Southern Med Univ, Sch Clin Med 2, Guangzhou, Peoples R China
[2] Southern Med Univ, Peoples Hosp Baoan Shenzhen, Shenzhen, Peoples R China
基金
中国国家自然科学基金;
关键词
tuberculosis; lncRNA; immune response; diagnosis; biomarker; T-CELLS RESPONSE; MYCOBACTERIUM-TUBERCULOSIS; GENE-REGULATION; MECHANISMS; LNCRNA; EVOLUTION; APOPTOSIS;
D O I
10.3389/fmicb.2022.883513
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) is the leading lethal infectious disease with 1.3 million deaths in 2020. Despite significant advances have been made in detection techniques and therapeutic approaches for tuberculosis, no suitable diagnostic tools are available for early and precise screening. Many studies have reported that Long non-coding RNAs (lncRNAs) play a regulatory role in gene expression in the host immune response against Mtb. Dysregulation of lncRNAs expression patterns associated with immunoregulatory pathways arose in mycobacterial infection. Meanwhile, host-induced lncRNAs regulate antibacterial processes such as apoptosis and autophagy to limit bacterial proliferation. In this review, we try to summarize the latest reports on how dysregulated expressed lncRNAs influence host immune response in tuberculosis infection. We also discuss their potential clinical prospects for tuberculosis diagnosis and development as molecular biomarkers.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets
    Gupta, Subash Chandra
    Tripathi, Yashoda Nandan
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (09) : 1955 - 1967
  • [22] Long non-coding RNAs as novel therapeutic targets in cancer
    Lavorgna, Giovanni
    Vago, Riccardo
    Sarmini, Mohamad
    Montorsi, Francesco
    Salonia, Andrea
    Bellone, Matteo
    PHARMACOLOGICAL RESEARCH, 2016, 110 : 131 - 138
  • [23] microRNAs and long non-coding RNAs as biomarkers for polycystic ovary syndrome
    Tamaddon, Mona
    Azimzadeh, Mostafa
    Tavangar, Seyed Mohammad
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2022, 26 (03) : 654 - 670
  • [24] Long non-coding RNAs as potential biomarkers and therapeutic targets for gliomas
    Sun, Yuanzhao
    Wang, Zhong
    Zhou, Dai
    MEDICAL HYPOTHESES, 2013, 81 (02) : 319 - 321
  • [25] Emerging Roles of Long Non-Coding RNAs in Cardiovascular Diseases
    Kong, Xiangyue
    Li, Fengjuan
    Wang, Yuan
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2025, 29 (05)
  • [26] Long Non-coding RNAs in the Regulation of the Immune Response and Trained Immunity
    Flores-Concha, Manuel
    Onate, Angel A.
    FRONTIERS IN GENETICS, 2020, 11
  • [27] Recent scenario of long non-coding RNAs as a diagnostic and prognostic biomarkers of prostate cancer
    Shukla, Kamla Kant
    Misra, Sanjeev
    Sankanagoudar, Shrimanjunath
    Sharma, Himanshu
    Choudhary, Gautam Ram
    Pareek, Puneet
    Vishnoi, Jeevan Ram
    Sharma, Praveen
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (12) : 918 - 928
  • [28] Role of non-coding RNAs in plant immunity
    Li Song
    Fang, Yu
    Chen, Lin
    Wang, Jing
    Chen, Xuewei
    PLANT COMMUNICATIONS, 2021, 2 (03)
  • [29] Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs
    Lulli, Matteo
    Napoli, Cristina
    Landini, Ida
    Mini, Enrico
    Lapucci, Andrea
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [30] From biomarkers to therapeutic targets—the promises and perils of long non-coding RNAs in cancer
    Tony Gutschner
    Georg Richtig
    Monika Haemmerle
    Martin Pichler
    Cancer and Metastasis Reviews, 2018, 37 : 83 - 105